Marken and BDI Pharma add to US cold-chain capacity
New operations center at JFK airport for Marken; new distribution center in Texas for BDI
Two companies involved with shipping and distribution of temperature-controlled life sciences products—clinical trial logistics provider Marken (Research Triangle Park, NC) and specialty distributor BDI Pharma (Columbia, SC)—have announced capacity expansions. BDI’s is close to the Dallas Fort Worth airport; for both, ready access to air freight is a driver.
In Marken’s case, an existing depot in the vicinity of JFK Airport, New York, has been complemented with a new, 10,000-sq. ft warehouse and operations center, closer to the airport. The company says that is equipped with the latest cold-chain equipment, and can handle the unit-load devices (ULDs) often used by life sciences shippers. “As customer demand increases for temperature controlled shipments, it made sense for our facilities to be in closer proximity to all major airlines and in a larger space to accommodate the growth we are experiencing in larger scale shipments,” said Kathy Gerson, a Marken VP, in a statement.
BDI Pharma, which has also expanded capacity at its Columbia HQ, is now licensed for national distribution from its DFW center, which it says doubles the company’s cold chain capacity. The second location also serves as a business-continuity backup for potential logistics upsets. BDI characterizes itself as a “niche distributor” of such specialty products as IVIG, chemotherapeutics, blood factors and others.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
